Protein A immunoadsorption therapy for refractory, mitomycin C-associated thrombotic microangiopathy

Transfusion

Volumn 47, Issue 7, 2007, Pages 1263-1267

  Kasper, Stefan ^a   Neurath, Markus F ^a   Huber, Christoph ^a   Theobald, Matthias ^a   Scharrer, Inge ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; IMMUNOGLOBULIN; MITOMYCIN C; PREDNISOLONE; PROTEIN A; RECOMBINANT ERYTHROPOIETIN; RITUXIMAB; VINCRISTINE;

ADULT; ARTICLE; ASTHENIA; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL EFFECTIVENESS; CORTICOSTEROID THERAPY; DEVICE; EXTRACORPOREAL CIRCULATION; FATIGUE; FEMALE; HEMOLYTIC ANEMIA; HUMAN; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; LAPAROSCOPIC SURGERY; LUNG EDEMA; MULTIPLE CYCLE TREATMENT; PATIENT SAFETY; PLASMAPHERESIS; SPLENECTOMY; THERAPY RESISTANCE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADULT; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; IMMUNOSORBENT TECHNIQUES; MITOMYCIN; PURPURA, THROMBOTIC THROMBOCYTOPENIC; SALVAGE THERAPY; STAPHYLOCOCCAL PROTEIN A; TREATMENT OUTCOME;

EID: 34250671470     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01266.x     Document Type: Article

References (39)

1. Cantrell JE Jr., Phillips TM, Schein PS. Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy. J Clin Oncol 1985 3 : 723 34.
2. Doll DC, Weiss RB, Issell BF. Mitomycin: ten years after approval for marketing. J Clin Oncol 1985 3 : 276 86.
3. Sheldon R, Slaughter D. A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma. Cancer 1986 58 : 1428 36.
4. Murgo AJ. Thrombotic microangiopathy in the cancer patient including those induced by chemotherapeutic agents. Semin Hematol 1987 24 : 161 77.
5. Lesesne JB, Rothschild N, Erickson B, et al. Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry. J Clin Oncol 1989 7 : 781 9.
6. George JN. Tibor Greenwalt Award. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: a program for patient care, education and research. Transfusion 2004 44 : 1384 92.
7. Kwaan HC. Thrombotic thrombocytopenic purpura: a diagnostic and therapeutic challenge. Semin Thromb Hemost 2005 31 : 615 24.
8. Veyradier A, Meyer D. Thrombotic thrombocytopenic purpura and its diagnosis. J Thromb Haemost 2005 3 : 2420 7. Review.
9. Snyder HW Jr., Mittelman A, Oral A, et al. Treatment of cancer chemotherapy-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma. Cancer 1993 71 : 1882 92.
10. Groff JA, Kozak M, Boehmer JP, Demko TM, Diamond JR. Endotheliopathy: a continuum of hemolytic uremic syndrome due to mitomycin therapy. Am J Kidney Dis 1997 29 : 280 4.
11. Medina PJ, Sipols JM, George JN. Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Curr Opin Hematol 2001 8 : 286 93.
12. George JN. Clinical practice: thrombotic thrombocytopenic purpura. N Engl J Med 2006 354 : 1927 35.
13. Korec S, Schein PS, Smith FP, et al. Treatment of cancer-associated hemolytic uremic syndrome with staphylococcal protein A immunoperfusion. J Clin Oncol 1986 4 : 210 5.
14. Watson PR, Guthrie TH Jr., Caruana RJ. Cisplatin-associated hemolytic-uremic syndrome: successful treatment with a staphylococcal protein A column. Cancer 1989 64 : 1400 3.
15. Nand S, Molokie R. Therapeutic plasmapheresis and protein A immunoadsorption in malignancy: a brief review. J Clin Apher 1990 5 : 206 12.
16. Durand JM, Lefevre P. Mitomycin-induced thrombotic thrombocytopenic purpura: possible successful treatment with vincristine and cyclophosphamide. Haematologica 1991 76 : 421 3.
17. Mant MJ, Turner AR, Bruce D, Ritchie C, Larratt LM. Splenectomy during partial remission in thrombotic thrombocytopenic purpura with prolonged plasma exchange dependency. Am J Hematol 1999 62 : 56 7.
18. McCarthy LJ, Dlott JS, Orazi A, et al. Thrombotic thrombocytopenic purpura: yesterday, today, tomorrow. Ther Apher Dial 2004 8 : 80 6.
19. Rock G. The management of thrombotic thrombocytopenic purpura in 2005. Semin Thromb Hemost 2005 31 : 709 16.
20. George JN. Review of efficacy of rituximab and concurrent plasma exchange in the treatment of thrombotic thrombocytopenic purpura and recurrent thrombotic thrombocytopenic purpura treated repeatedly and successfully with the monoclonal antibody rituximab. Clin Adv Hematol Oncol 2006 4 : 217 8.
21. Hull MJ, Eichbaum QG. Efficacy of rituximab and concurrent plasma exchange in the treatment of thrombotic thrombocytopenic purpura. Clin Adv Hematol Oncol 2006 4 : 210 4 discussion 217 8.
22. Bohm M, Vigh T, Scharrer I. Evaluation and clinical application of a new method for measuring activity of von Willebrand factor-cleaving metalloprotease (ADAMTS13). Ann Hematol 2002 81 : 430 5.
23. Tripodi A, Chantarangkul V, Bohm M, et al. Measurement of von Willebrand factor cleaving protease (ADAMTS-13): results of an international collaborative study involving 11 methods testing the same set of coded plasmas. J Thromb Haemost 2004 2 : 1601 9.
24. Gallerani E, Lerch E, Romagnani E, et al. Thrombotic thrombocytopenic purpura associated with renal failure after autologous transplantation for multiple myeloma successfully treated with rituximab. Eur J Haematol 2006 77 : 527 9.
25. Yassa SK, Blessios G, Marinides G, Venuto RC. Anti-CD20 monoclonal antibody (Rituximab) for life-threatening hemolytic-uremic syndrome. Clin Transplant 2005 19 : 423 6.
26. Ferrara F, Annunziata M, Pollio F, et al. Vincristine as treatment for recurrent episodes of thrombotic thrombocytopenic purpura. Ann Hematol 2002 81 : 7 10.
27. Mateos J, Perez-Simon JA, Caballero D, et al. Vincristine is an effective therapeutic approach for transplantation-associated thrombotic microangiopathy. Bone Marrow Transplant 2006 37 : 337 8.
28. Bohm M, Betz C, Miesbach W, et al. The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine. Br J Haematol 2005 129 : 644 52.
29. McMinn JR Jr., Thomas IA, Terrell DR, et al. Complications of plasma exchange in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a study of 78 additional patients. Transfusion 2003 43 : 415 6.
30. de la Rubia J, Plume G, Arriaga F, et al. Platelet transfusion and thrombotic thrombocytopenic purpura. Transfusion 2002 42 : 1384 5.
31. Lozano M, Domingo A, Pereira A, Fontanals J, Mazzara R. Platelet transfusion in thrombotic thrombocytopenic purpura: between Scylla and Charybdis. Transfusion 2005 45 : 1984.
32. Aqui NA, Stein SH, Konkle BA, Abrams CS, Strobl FJ. Role of splenectomy in patients with refractory or relapsed thrombotic thrombocytopenic purpura. J Clin Apher 2003 18 : 51 4.
33. Kremer Hovinga JA, Studt JD, Demarmels Biasiutti F, et al. Splenectomy in relapsing and plasma-refractory acquired thrombotic thrombocytopenic purpura. Haematologica 2004 89 : 320 4.
34. Kappers-Klunne MC, Wijermans P, Fijnheer R, et al. Splenectomy for the treatment of thrombotic thrombocytopenic purpura. Br J Haematol 2005 130 : 768 76.
35. Zeigler ZR, Shadduck RK, Nath R, Andrews DF 3rd. Pilot study of combined cryosupernatant and protein A immunoadsorption exchange in the treatment of grade 3-4 bone marrow transplant-associated thrombotic microangiopathy. Bone Marrow Transplant 1996 17 : 81 6.
36. Fontana S, Kremer Hovinga JA, Lammle B, Mansouri Taleghani B. Treatment of thrombotic thrombocytopenic purpura. Vox Sang 2006 90 : 245 54.
37. Toepfer M, Sitter T, Burchardi C, Held E, Schiffl H. [Clinical immunoadsorption]. Dtsch Med Wochenschr 1999 124 : 461 5.
38. Laurence J, Mitra D, Steiner M, Staiano-Coico L, Jaffe E. Plasma from patients with idiopathic and human immunodeficiency virus-associated thrombotic thrombocytopenic purpura induces apoptosis in microvascular endothelial cells. Blood 1996 87 : 3245 54.
39. Seki Y, Toba K, Fuse I, et al. In vitro effect of cyclosporin A, mitomycin C and prednisolone on cell kinetics in cultured human umbilical vein endothelial cells. Thromb Res 2005 115 : 219 28.